Born Againepisode 2 showcases The Punisher's logo for the first time, only with a slightly different look and sported by an ...

HPV16+ Cancers Market Insights, Epidemiology, and Market Forecast – 2034 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, ...

Dan Victor has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Merck. The Motley Fool has a disclosure policy.

It's been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar fourth-quarter earnings report. Even as the pharmaceutical giant exceeded Wall Street estimates ...

Merck, which is "pleased" with the decision to adjourn, agreed under the stipulation that it would provide “no financial or other consideration” in exchange for the agreement, a company ...

Merck said it’s pleased that a judge agreed to reset the trial for September with a new jury. In a statement, the company said it “would provide no financial or other consideration in exchange ...

Merck agreed "subject to an explicit stipulation that Merck would provide no financial or other consideration in exchange for the agreement to adjourn," the company said. The plaintiff in the case, ...

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey ...

Merck agreed "subject to an explicit stipulation that Merck would provide no financial or other consideration in exchange for the agreement to adjourn," the company said. Mark Lanier, an attorney for ...

Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a price target of $105, down from $128. The firm believes the “real culprit” for Merck shares remaining under ...